Selected research
Industry Research
Immune Cell Banking Service Industry Research Report 2026
Market perspective
The global Immune Cell Banking Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Immune Cell Banking Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Immune Cell Banking Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Immune Cell Banking Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Immune Cell Banking Service include HealthBanks, BioLife Solutions, Sartorius, ThermoGenesis, Charles River, Biorep Technologies, Cryo-Cell International, CGT GLOBAL and Cordlife Group, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Immune Cell Banking Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Immune Cell Banking Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Immune Cell Banking Service Market by Company
HealthBanks
BioLife Solutions
Sartorius
ThermoGenesis
Charles River
Biorep Technologies
Cryo-Cell International
CGT GLOBAL
Cordlife Group
Celularity
Boyalife
Beike Biotechnology
Forever Labs
Redermis
LifeCell International
VCANBIO
BGI Group
Shanghai Cell Therapy Group
Immune Cell Banking Service Segment by Type
Neonatal Immune Cell Storage
Adult Immune Cell Storage
Immune Cell Banking Service Segment by Application
Medical Scene
Non-medical Scene
Immune Cell Banking Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune Cell Banking Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immune Cell Banking Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune Cell Banking Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Immune Cell Banking Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Neonatal Immune Cell Storage
- Adult Immune Cell Storage
Applications
- Medical Scene
- Non-medical Scene
Companies covered
- HealthBanks
- BioLife Solutions
- Sartorius
- ThermoGenesis
- Charles River
- Biorep Technologies
- Cryo-Cell International
- CGT GLOBAL
- Cordlife Group
- Celularity
- Boyalife
- Beike Biotechnology
- Forever Labs
- Redermis
- LifeCell International
- VCANBIO
- BGI Group
- Shanghai Cell Therapy Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Immune Cell Banking Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Neonatal Immune Cell Storage
- 2.2.3 Adult Immune Cell Storage
- 2.3 Immune Cell Banking Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Medical Scene
- 2.3.3 Non-medical Scene
- 2.4 Assumptions and Limitations
3 Immune Cell Banking Service Breakdown Data by Type
- 3.1 Global Immune Cell Banking Service Historic Market Size by Type (2021-2026)
- 3.2 Global Immune Cell Banking Service Forecasted Market Size by Type (2027-2032)
4 Immune Cell Banking Service Breakdown Data by Application
- 4.1 Global Immune Cell Banking Service Historic Market Size by Application (2021-2026)
- 4.2 Global Immune Cell Banking Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Immune Cell Banking Service Market Perspective (2021-2032)
- 5.2 Global Immune Cell Banking Service Growth Trends by Region
- 5.2.1 Global Immune Cell Banking Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Immune Cell Banking Service Historic Market Size by Region (2021-2026)
- 5.2.3 Immune Cell Banking Service Forecasted Market Size by Region (2027-2032)
- 5.3 Immune Cell Banking Service Market Dynamics
- 5.3.1 Immune Cell Banking Service Industry Trends
- 5.3.2 Immune Cell Banking Service Market Drivers
- 5.3.3 Immune Cell Banking Service Market Challenges
- 5.3.4 Immune Cell Banking Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Immune Cell Banking Service Players by Revenue
- 6.1.1 Global Top Immune Cell Banking Service Players by Revenue (2021-2026)
- 6.1.2 Global Immune Cell Banking Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Immune Cell Banking Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Immune Cell Banking Service Head Office and Area Served
- 6.4 Global Immune Cell Banking Service Players, Product Type & Application
- 6.5 Global Immune Cell Banking Service Manufacturers Established Date
- 6.6 Global Immune Cell Banking Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Immune Cell Banking Service Market Size (2021-2032)
- 7.2 North America Immune Cell Banking Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Immune Cell Banking Service Market Size by Country (2021-2026)
- 7.4 North America Immune Cell Banking Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Immune Cell Banking Service Market Size (2021-2032)
- 8.2 Europe Immune Cell Banking Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Immune Cell Banking Service Market Size by Country (2021-2026)
- 8.4 Europe Immune Cell Banking Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Immune Cell Banking Service Market Size (2021-2032)
- 9.2 Asia-Pacific Immune Cell Banking Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Immune Cell Banking Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Immune Cell Banking Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Immune Cell Banking Service Market Size (2021-2032)
- 10.2 South America Immune Cell Banking Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Immune Cell Banking Service Market Size by Country (2021-2026)
- 10.4 South America Immune Cell Banking Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Immune Cell Banking Service Market Size (2021-2032)
- 11.2 Middle East & Africa Immune Cell Banking Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Immune Cell Banking Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Immune Cell Banking Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 HealthBanks
- 12.1.1 HealthBanks Company Information
- 12.1.2 HealthBanks Business Overview
- 12.1.3 HealthBanks Revenue in Immune Cell Banking Service Business (2021-2026)
- 12.1.4 HealthBanks Immune Cell Banking Service Product Portfolio
- 12.1.5 HealthBanks Recent Developments
- 12.2 BioLife Solutions
- 12.2.1 BioLife Solutions Company Information
- 12.2.2 BioLife Solutions Business Overview
- 12.2.3 BioLife Solutions Revenue in Immune Cell Banking Service Business (2021-2026)
- 12.2.4 BioLife Solutions Immune Cell Banking Service Product Portfolio
- 12.2.5 BioLife Solutions Recent Developments
- 12.3 Sartorius
- 12.3.1 Sartorius Company Information
- 12.3.2 Sartorius Business Overview
- 12.3.3 Sartorius Revenue in Immune Cell Banking Service Business (2021-2026)
- 12.3.4 Sartorius Immune Cell Banking Service Product Portfolio
- 12.3.5 Sartorius Recent Developments
- 12.4 ThermoGenesis
- 12.4.1 ThermoGenesis Company Information
- 12.4.2 ThermoGenesis Business Overview
- 12.4.3 ThermoGenesis Revenue in Immune Cell Banking Service Business (2021-2026)
- 12.4.4 ThermoGenesis Immune Cell Banking Service Product Portfolio
- 12.4.5 ThermoGenesis Recent Developments
- 12.5 Charles River
- 12.5.1 Charles River Company Information
- 12.5.2 Charles River Business Overview
- 12.5.3 Charles River Revenue in Immune Cell Banking Service Business (2021-2026)
- 12.5.4 Charles River Immune Cell Banking Service Product Portfolio
- 12.5.5 Charles River Recent Developments
- 12.6 Biorep Technologies
- 12.6.1 Biorep Technologies Company Information
- 12.6.2 Biorep Technologies Business Overview
- 12.6.3 Biorep Technologies Revenue in Immune Cell Banking Service Business (2021-2026)
- 12.6.4 Biorep Technologies Immune Cell Banking Service Product Portfolio
- 12.6.5 Biorep Technologies Recent Developments
- 12.7 Cryo-Cell International
- 12.7.1 Cryo-Cell International Company Information
- 12.7.2 Cryo-Cell International Business Overview
- 12.7.3 Cryo-Cell International Revenue in Immune Cell Banking Service Business (2021-2026)
- 12.7.4 Cryo-Cell International Immune Cell Banking Service Product Portfolio
- 12.7.5 Cryo-Cell International Recent Developments
- 12.8 CGT GLOBAL
- 12.8.1 CGT GLOBAL Company Information
- 12.8.2 CGT GLOBAL Business Overview
- 12.8.3 CGT GLOBAL Revenue in Immune Cell Banking Service Business (2021-2026)
- 12.8.4 CGT GLOBAL Immune Cell Banking Service Product Portfolio
- 12.8.5 CGT GLOBAL Recent Developments
- 12.9 Cordlife Group
- 12.9.1 Cordlife Group Company Information
- 12.9.2 Cordlife Group Business Overview
- 12.9.3 Cordlife Group Revenue in Immune Cell Banking Service Business (2021-2026)
- 12.9.4 Cordlife Group Immune Cell Banking Service Product Portfolio
- 12.9.5 Cordlife Group Recent Developments
- 12.10 Celularity
- 12.10.1 Celularity Company Information
- 12.10.2 Celularity Business Overview
- 12.10.3 Celularity Revenue in Immune Cell Banking Service Business (2021-2026)
- 12.10.4 Celularity Immune Cell Banking Service Product Portfolio
- 12.10.5 Celularity Recent Developments
- 12.11 Boyalife
- 12.11.1 Boyalife Company Information
- 12.11.2 Boyalife Business Overview
- 12.11.3 Boyalife Revenue in Immune Cell Banking Service Business (2021-2026)
- 12.11.4 Boyalife Immune Cell Banking Service Product Portfolio
- 12.11.5 Boyalife Recent Developments
- 12.12 Beike Biotechnology
- 12.12.1 Beike Biotechnology Company Information
- 12.12.2 Beike Biotechnology Business Overview
- 12.12.3 Beike Biotechnology Revenue in Immune Cell Banking Service Business (2021-2026)
- 12.12.4 Beike Biotechnology Immune Cell Banking Service Product Portfolio
- 12.12.5 Beike Biotechnology Recent Developments
- 12.13 Forever Labs
- 12.13.1 Forever Labs Company Information
- 12.13.2 Forever Labs Business Overview
- 12.13.3 Forever Labs Revenue in Immune Cell Banking Service Business (2021-2026)
- 12.13.4 Forever Labs Immune Cell Banking Service Product Portfolio
- 12.13.5 Forever Labs Recent Developments
- 12.14 Redermis
- 12.14.1 Redermis Company Information
- 12.14.2 Redermis Business Overview
- 12.14.3 Redermis Revenue in Immune Cell Banking Service Business (2021-2026)
- 12.14.4 Redermis Immune Cell Banking Service Product Portfolio
- 12.14.5 Redermis Recent Developments
- 12.15 LifeCell International
- 12.15.1 LifeCell International Company Information
- 12.15.2 LifeCell International Business Overview
- 12.15.3 LifeCell International Revenue in Immune Cell Banking Service Business (2021-2026)
- 12.15.4 LifeCell International Immune Cell Banking Service Product Portfolio
- 12.15.5 LifeCell International Recent Developments
- 12.16 VCANBIO
- 12.16.1 VCANBIO Company Information
- 12.16.2 VCANBIO Business Overview
- 12.16.3 VCANBIO Revenue in Immune Cell Banking Service Business (2021-2026)
- 12.16.4 VCANBIO Immune Cell Banking Service Product Portfolio
- 12.16.5 VCANBIO Recent Developments
- 12.17 BGI Group
- 12.17.1 BGI Group Company Information
- 12.17.2 BGI Group Business Overview
- 12.17.3 BGI Group Revenue in Immune Cell Banking Service Business (2021-2026)
- 12.17.4 BGI Group Immune Cell Banking Service Product Portfolio
- 12.17.5 BGI Group Recent Developments
- 12.18 Shanghai Cell Therapy Group
- 12.18.1 Shanghai Cell Therapy Group Company Information
- 12.18.2 Shanghai Cell Therapy Group Business Overview
- 12.18.3 Shanghai Cell Therapy Group Revenue in Immune Cell Banking Service Business (2021-2026)
- 12.18.4 Shanghai Cell Therapy Group Immune Cell Banking Service Product Portfolio
- 12.18.5 Shanghai Cell Therapy Group Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst